SPLYZA Inc. (Headquarters: Hamamatsu City, Shizuoka Prefecture, Representative Director: Hiroyuki Doi, hereinafter "SPLYZA"), which supports "sports education and healthcare" through application development, and The University of Tokyo Hospital, Department of Orthopedic Surgery and Spine Surgery (Headquarters: Bunkyo-ku, Tokyo, Acting Hospital Director: Haruki Kume, hereinafter "The University of Tokyo Hospital"), signed a joint research agreement on March 17, 2026, regarding motion analysis technology utilizing "SPLYZA Motion," an AI-powered markerless 3D motion analysis app provided by SPLYZA.

【Research Background】 Currently, musculoskeletal diseases are cited as one of the primary causes of requiring long-term care in Japan. Among these, hip osteoarthritis significantly affects walking and standing movements, greatly reducing the quality of life (QOL). However, conventional clinical evaluations primarily rely on visual observation and photography from specific directions, making it difficult to easily and accurately quantify complex pelvic movements or left-right differences during walking.

This joint research aims to apply the AI analysis technology of "SPLYZA Motion," which prioritizes ease of use in clinical settings, to establish optimized multi-angle shooting protocols for patients with musculoskeletal diseases and improve measurement accuracy.

【About The University of Tokyo Hospital】 The University of Tokyo Hospital, originating from the Kanda Otamagaike Smallpox Vaccination Center established in 1858, is a hospital with over 160 years of history and tradition that has supported modern medical education in Japan. To fulfill its mission as a university hospital, it operates under the philosophy of "striving for the development of clinical medicine and the training of medical professionals, and providing optimal medical care to individual patients," engaging in clinical practice, research, and education.

【What is SPLYZA Motion?】 https://motion.products.splyza.com/ An AI-powered markerless 3D motion analysis app. The service was launched in 2022, and as of April 2026, it has been introduced in over 200 facilities, including educational institutions and medical facilities.

【About SPLYZA Inc.】 https://www.splyza.com/ Company Name: SPLYZA Inc. Location: 16-13 Aioicho, Chuo-ku, Hamamatsu City, Shizuoka Prefecture Representative: Hiroyuki Doi, Representative Director Factbook: https://www.splyza.com/company/factbook.html

FACT BOX

  • Source: PR TIMES
  • Category: research